(a) PFS and (b) OS of ATC patients demonstrating positive or negative staining (determined by Allred-like score) for PD-L1 in their inflammatory cells. (c) PFS and (d) OS of ATC patients demonstrating ≤40% or >40% staining for PD-1 in their inflammatory cells.